Pharmaceutical prices in the U.S. are pushing patients to have their prescriptions filled in Canada, where drugs such as Lipitor cost less. Budget-conscious state governments are also eyeing Canadian distributors as a way to manage their prescription plans while making fiscal ends meet. But officially speaking, such transactions are still illegal in the U.S.—and the medicines themselves, traveling outside the domain of the FDA, may not even be safe. In this two-segment program, NewsHour health correspondent Susan Dentzer taps senators, governors, FDA officials, pharmacists, and the CEO of drug manufacturing giant Pfizer to present a balanced view of one of today’s most controversial topics. (22 minutes)